Datta

Surgical oncologist Rajiv Datta, M.D., has been selected for inclusion “Top Doctors: New York Metro Area.” This is the sixth consecutive year that Datta will be included in the acclaimed guide from Castle Connolly Medical Ltd., which spotlights the top 10 percent of primary care and specialty care physicians in the tri-state New York area.

“My successes and the quality of the care my patients receive is a direct result of the team of oncologists, nurses, technicians, and administrators that I work and collaborate with on a daily basis here at South Nassau,” said Datta, chair of the department of surgery and medical director of the Gertrude & Louis Feil Cancer Center at South Nassau Communities Hospital.

Under Datta’s leadership, the Gertrude & Louis Feil Cancer Center has evolved into one of the Northeast corridor’s premiere providers of compassionate advanced cancer care.  The center is the only one on Long Island that is equipped with three of the most advanced and effective technologies used to treat and eradicate cancer: the Varian Novalis Tx, da Vinci Surgical System and Gamma Knife Perfexion.  It is a recipient of many prestigious honors and citations, including the American College of Surgeons Comprehensive Community Cancer Center and the Commission on Cancer Outstanding Achievement Award.

Datta is listed in the “Colon and Rectal Surgery” section of the Castle Connolly guide.  Doctors listed in its “top doctors” series of guides are selected after peer nomination, extensive research and careful review and screening.  The Castle Connolly physician-led research team reviews the medical education, training, hospital appointments, disciplinary history and more of each nominee.  Doctors do not pay to be included in a Castle Connolly guide or list.

Datta’s areas of expertise include cancer of the colon/rectum, endocrine system, breast and head and neck; soft tissue sarcoma and melanoma; upper gastrointestinal and colorectal procedures; tracheal and esophageal surgeries and radio frequency ablation for liver tumors. Datta also is actively involved in numerous clinical trials that are both federally and privately funded.